The company's microneedle patch technology simplifies and improves the delivery, storage, and distribution of drugs and vaccines, increasing patient access and improving safety and efficacy. Micron Biomedical is focused on developing microneedle patches for influenza and polio vaccines, aiming to provide enhanced protective and therapeutic effects, superior patient compliance, and simplified administration.